Volume 77, Issue 4
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645


In patients with meningococcal infection, devastating presentations, such as purpura fulminans, which can progress to extensive tissue necrosis of the limbs and digits, have a significant social impact. The case presented herein illustrates such a phenomenon in a patient who developed bilateral necrosis of the lower extremities as a result of infection with . We emphasize that severe myalgia was the first clinical manifestation of meningococcal purpura fulminans in our case. However, myalgia has typically been overlooked and undervalued as an early clinical feature of meningococcal sepsis. Early recognition and prompt initial antibiotic therapy continue to be the cornerstones of the successful management of this dramatic disease, reducing morbidity and mortality.


Article metrics loading...

Loading full text...

Full text loading...



  1. Thompson MJ, Ninis N, Perera R, Mayon-White R, Phillips C, Bailey L, Harnden A, Mant D, Levin M, 2006. Clinical recognition of meningococcal disease in children and adolescents. Lancet 367 : 397–403.
  2. Inkelis SH, O’Leary D, Wang VJ, Malley R, Nicholson MK, Kuppermann N, 2002. Extremity pain and refusal to walk in children with invasive meningococcal disease. Pediatrics 110 : e3.
  3. Carrol ED, Thomson AP, Mobbs KJ, Fraser WD, Sills JA, Hart CA, 2002. Myositis in children with meningococcal disease: a role for tumour necrosis factor-alpha and interleukin-8? J Infect 44 : 17–21.
  4. Taha M, 2000. Simultaneous approach for nonculture PCR-based identification and serogroup prediction of Neisseria meningitidis. J Clin Microbiol 38 : 855–857.
  5. Zenz W, Zoehrer B, Levin M, Fanconi S, Hatzis TD, Knight G, Mullner M, Faust SN, International Paediatric Meningococcal Thrombolysis Study Group, 2004. Use of recombinant tissue plasminogen activator in children with meningococcal purpura fulminans: a retrospective study. Crit Care Med 32 : 1777–1780.
  6. Dixon JE, Fearneyhough PK, Callen JP, 2006. Thwarting a killer. Am J Med 119 : 310–311.
  7. van Deuren M, van Dijke BJ, Koopman RJ, Horrevorts AM, Meis JF, Santman FW, van der Meer JW, 1993. Rapid diagnosis of acute meningococcal infections by needle aspiration or biopsy of skin lesions. BMJ 306 : 1229–1232.
  8. Apicella MA, 2005. Neisseria meningitidis. Mandell GL, Douglas RG, and Bennett JE, eds. Principles and Practices of Infectious Diseases. 6th ed. New York: Churchill Livingstone, 2498–2513.
  9. Hermans PW, Hibberd ML, Booy R, Daramola O, Hazelzet JA, de Groot R, Levin M, 1999. 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease. Lancet 354 : 556–560.
  10. Warner PM, Kagan RJ, Yakuboff KP, Kemalyan N, Palmieri TL, Greenhalgh DG, Sheridan RL, Mozingo DW, Heimbach DM, Gibran NS, Engrav L, Saffle JR, Edelman LS, Warden GD, 2003. Current management of purpura fulminans: a multi-center study. J Burn Care Rehabil 24 : 119–126.
  11. Emonts M, Hazelzet JA, de Groot R, Hermans PW, 2003. Host genetic determinants of Neisseria meningitidis infections. Lancet Infect Dis 3 : 565–577.
  12. Bjerre A, Ovstebo R, Kierulf P, Halvorsen S, Brandtzaeg P, 2000. Fulminant meningococcal septicemia: dissociation between plasma thrombopoietin levels and platelet counts. Clin Infect Dis 30 : 643–647.
  13. Faust SN, Levin M, Harrison OB, Goldin RD, Lockhart MS, Kondaveeti S, Laszik Z, Esmon CT, Heyderman RS, 2001. Dysfunction of endothelial protein C activation in severe meningococcal sepsis. N Engl J Med 345 : 408–416.
  14. Van Amersfoort ES, Van Berkel TJ, Kuiper J, 2003. Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock. Clin Microbiol Rev 16 : 379–414.
  15. Constantin D, Cordenier A, Robinson K, Ala’Aldeen DA, Murphy S, 2004. Neisseria meningitidis-induced death of cerebrovascular endothelium: mechanisms triggering transcriptional activation of inducible nitric oxide synthase. J Neuro-chem 89 : 1166–1174.
  16. Sotto MN, Langer B, Hoshino-Shimizu S, de Brito T, 1976. Pathogenesis of cutaneous lesions in acute meningococcemia in humans: light, immunofluorescent, and electron microscopic studies of skin biopsy specimens. J Infect Dis 133 : 506–514.
  17. Hoyne AL, Brown RH, 1948. 727 meningococcic cases: an analysis. Ann Intern Med 28 : 248–259.
  18. van Deuren M, Brandtzaeg P, van der Meer JW, 2000. Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin Microbiol Rev 13 : 144–166.
  19. de Souza AL, Sztajnbok J, Marques Salgado M, Romano CC, Alkmin MG, Duarte AJ, Seguro AC, 2006. Compartmentalization of interleukin-6 response in a patient with septic meningococcal peritonitis. Clin Vaccine Immunol 13 : 1287–1290.
  20. Guarner J, Greer PW, Whitney A, Shieh WJ, Fischer M, White EH, Carlone GM, Stephens DS, Popovic T, Zaki SR, 2004. Pathogenesis and diagnosis of human meningococcal disease using immunohistochemical and PCR assays. Am J Clin Pathol 122 : 754–764.
  21. Arend SM, Lavrijsen AP, Kuijken I, van der Plas RN, Kuijper EJ, 2006. Prospective controlled study of the diagnostic value of skin biopsy in patients with presumed meningococcal disease. Eur J Clin Microbiol Infect Dis 25 : 643–649.

Data & Media loading...

  • Received : 29 Nov 2006
  • Accepted : 23 Jan 2007

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error